And we know that, although it's great to make those anti-malarial drugs available at really low cost and high frequency, we know that when you make them highly available you're going to get resistance to those drugs.
Y sabemos que, aunque es maravilloso que logremos que esos medicamentos estén disponible a bajo precio y en grandes cantidades, sabemos que cuando hay gran disponibilidad obtendremos resistencia a esos medicamentos.